Using models to shape measles control and elimination strategies in low- and middle-income countries: A review of recent applications
- PMID: 31787412
- PMCID: PMC6996156
- DOI: 10.1016/j.vaccine.2019.11.020
Using models to shape measles control and elimination strategies in low- and middle-income countries: A review of recent applications
Abstract
After many decades of vaccination, measles epidemiology varies greatly between and within countries. National immunization programs are therefore encouraged to conduct regular situation analyses and to leverage models to adapt interventions to local needs. Here, we review applications of models to develop locally tailored interventions to support control and elimination efforts. In general, statistical and semi-mechanistic transmission models can be used to synthesize information from vaccination coverage, measles incidence, demographic, and/or serological data, offering a means to estimate the spatial and age-specific distribution of measles susceptibility. These estimates complete the picture provided by vaccination coverage alone, by accounting for natural immunity. Dynamic transmission models can then be used to evaluate the relative impact of candidate interventions for measles control and elimination and the expected future epidemiology. In most countries, models predict substantial numbers of susceptible individuals outside the age range of routine vaccination, which affects outbreak risk and necessitates additional intervention to achieve elimination. More effective use of models to inform both vaccination program planning and evaluation requires the development of training to enhance broader understanding of models and where feasible, building capacity for modelling in-country, pipelines for rapid evaluation of model predictions using surveillance data, and clear protocols for incorporating model results into decision-making.
Keywords: Elimination; Epidemiology; Mathematical models; Measles; Measles vaccination; Rubella.
Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures





Similar articles
-
Strengthening routine immunization through measles-rubella elimination.Vaccine. 2018 Sep 5;36(37):5645-5650. doi: 10.1016/j.vaccine.2018.07.029. Epub 2018 Jul 21. Vaccine. 2018. PMID: 30041881 Free PMC article.
-
Vaccination strategies for measles control and elimination: time to strengthen local initiatives.BMC Med. 2021 Jan 5;19(1):2. doi: 10.1186/s12916-020-01843-z. BMC Med. 2021. PMID: 33397366 Free PMC article.
-
Exploring landscape of measles vaccination coverage: A step towards measles elimination goal in India.Vaccine. 2024 Jun 20;42(17):3637-3646. doi: 10.1016/j.vaccine.2024.04.075. Epub 2024 May 3. Vaccine. 2024. PMID: 38704248 Free PMC article.
-
Measles vaccination in an increasingly immunized and developed world.Hum Vaccin Immunother. 2019;15(1):28-33. doi: 10.1080/21645515.2018.1517074. Epub 2018 Sep 19. Hum Vaccin Immunother. 2019. PMID: 30156949 Free PMC article. Review.
-
Measles, mumps, rubella prevention: how can we do better?Expert Rev Vaccines. 2021 Jul;20(7):811-826. doi: 10.1080/14760584.2021.1927722. Epub 2021 Jun 7. Expert Rev Vaccines. 2021. PMID: 34096442 Review.
Cited by
-
Development and dissemination of infectious disease dynamic transmission models during the COVID-19 pandemic: what can we learn from other pathogens and how can we move forward?Lancet Digit Health. 2021 Jan;3(1):e41-e50. doi: 10.1016/S2589-7500(20)30268-5. Epub 2020 Dec 7. Lancet Digit Health. 2021. PMID: 33735068 Free PMC article. Review.
-
Analysis of the different interventions scenario for programmatic measles control in Bangladesh: A modelling study.PLoS One. 2023 Jun 29;18(6):e0283082. doi: 10.1371/journal.pone.0283082. eCollection 2023. PLoS One. 2023. PMID: 37384663 Free PMC article.
-
Measles seroprevalence in persons over one year of age in Chandigarh, India.Hum Vaccin Immunother. 2022 Nov 30;18(6):2136453. doi: 10.1080/21645515.2022.2136453. Epub 2022 Oct 24. Hum Vaccin Immunother. 2022. PMID: 36279515 Free PMC article.
-
Challenges in measuring supplemental immunization activity coverage among measles zero-dose children.Vaccine. 2021 Mar 1;39(9):1359-1363. doi: 10.1016/j.vaccine.2020.11.050. Epub 2021 Feb 4. Vaccine. 2021. PMID: 33551302 Free PMC article.
-
Optimal Timing Regularly Outperforms Higher Coverage in Preventative Measles Supplementary Immunization Campaigns.Vaccines (Basel). 2024 Jul 22;12(7):820. doi: 10.3390/vaccines12070820. Vaccines (Basel). 2024. PMID: 39066459 Free PMC article.
References
-
- World Health Organization. Global vaccine action plan 2011–2020; 2013. https://www.who.int/immunization/global_vaccine_action_plan/GVAP_doc_201... [accessed July 2, 2019].
-
- World Health Organization Measles vaccines: WHO position paper. Wkly Epidemiol Rec. 2017;92:205–228. - PubMed
-
- World Health Organization Rubella vaccines: WHO position paper. Wkly Epidemiol Rec. 2011;86:301–316. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical